Relay Therapeutics to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

Relay Therapeutics, Inc. (RLAY) will participate in three upcoming fireside chats at major healthcare conferences in March 2024. The company aims to showcase its innovative approach to drug discovery using computational and experimental technologies.

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in three upcoming fireside chats:

• TD Cowen’s 44^th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ET
• Leerink Partners’ 2024 Global Biopharma Conference on Monday, March 11, 2024 at 10:40 a.m. ET
• Barclays 26^th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 7:30 a.m. ET
  

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Megan Goulart
617-545-5526
mgoulart@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Relay Therapeutics (RLAY) participate in the TD Cowen's 44th Annual Health Care Conference?

Relay Therapeutics will participate in TD Cowen's 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ET.

What is the focus of Relay Therapeutics (RLAY) in transforming the drug discovery process?

Relay Therapeutics focuses on transforming the drug discovery process by combining leading-edge computational and experimental technologies.

Where can investors access the webcast of Relay Therapeutics' (RLAY) fireside chats?

Investors can access the webcast of Relay Therapeutics' fireside chats on the company's website under Events in the News & Events section through the provided link.

How long will the archived replay of the webcast be available?

The archived replay of the webcast will be available for up to 30 days following the event.